Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Bayer plc, 400 South Oak Way, Reading, RG2 6AD
Progynova 1mg Tablets.
| Pharmaceutical Form |
|---|
|
Pale yellow sugar coated tablet for oral administration. |
Each memo pack contains 28 tablets each containing estradiol valerate 1.0 mg.
Excipients with known effect:
Lactose monohydrate and sucrose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Estradiol |
Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Container consists of aluminium foil and PVC blister strips packed in a cardboard carton.
Presentation: Carton containing memo-packs of either 1 × 28 tablets or 3 × 28 tablets.
Bayer plc, 400 South Oak Way, Reading, RG2 6AD
PL 00010/0556
1 May 2008
| Drug | Countries | |
|---|---|---|
| PROGYNOVA | Austria, Australia, Germany, Spain, Finland, France, Israel, Malta, Netherlands, New Zealand, Singapore, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
